These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 19722231

  • 1. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
    Ren DN, Kim IY, Koh SB, Chang SJ, Eom M, Yi SY, Seong SH, Kim MD, Bronner MP, Cho MY.
    J Surg Oncol; 2009 Dec 01; 100(7):546-52. PubMed ID: 19722231
    [Abstract] [Full Text] [Related]

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Dec 01; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 3. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer.
    Merkelbach-Bruse S, Hans V, Mathiak M, Sanguedolce R, Alessandro R, Rüschoff J, Büttner R, Houshdaran F, Gullotti L.
    Oncol Rep; 2004 Apr 01; 11(4):839-43. PubMed ID: 15010882
    [Abstract] [Full Text] [Related]

  • 4. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4116-24. PubMed ID: 14519634
    [Abstract] [Full Text] [Related]

  • 5. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.
    Ishida Y, Kawakami K, Tanaka Y, Kanehira E, Omura K, Watanabe G.
    Anticancer Res; 2002 Sep 15; 22(5):2805-9. PubMed ID: 12530000
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H, Iinuma H, Watanabe T.
    Oncol Rep; 2008 Mar 15; 19(3):729-35. PubMed ID: 18288408
    [Abstract] [Full Text] [Related]

  • 7. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
    Dotor E, Cuatrecases M, Martínez-Iniesta M, Navarro M, Vilardell F, Guinó E, Pareja L, Figueras A, Molleví DG, Serrano T, de Oca J, Peinado MA, Moreno V, Germà JR, Capellá G, Villanueva A.
    J Clin Oncol; 2006 Apr 01; 24(10):1603-11. PubMed ID: 16575011
    [Abstract] [Full Text] [Related]

  • 8. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.
    Tsuji T, Hidaka S, Sawai T, Nakagoe T, Yano H, Haseba M, Komatsu H, Shindou H, Fukuoka H, Yoshinaga M, Shibasaki S, Nanashima A, Yamaguchi H, Yasutake T, Tagawa Y.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3700-4. PubMed ID: 14506161
    [Abstract] [Full Text] [Related]

  • 9. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
    Mauritz R, Giovannetti E, Beumer IJ, Smid K, Van Groeningen CJ, Pinedo HM, Peters GJ.
    Clin Colorectal Cancer; 2009 Jul 01; 8(3):146-54. PubMed ID: 19632929
    [Abstract] [Full Text] [Related]

  • 10. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T, Ferraz JM, Zinzindohoué F, Loriot MA, Tregouet DA, Landi B, Berger A, Cugnenc PH, Jian R, Beaune P, Laurent-Puig P.
    Clin Cancer Res; 2004 Sep 01; 10(17):5880-8. PubMed ID: 15355920
    [Abstract] [Full Text] [Related]

  • 11. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
    Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E.
    Eur J Cancer; 2005 Sep 01; 41(14):2176-83. PubMed ID: 16182121
    [Abstract] [Full Text] [Related]

  • 12. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
    Xi Y, Formentini A, Nakajima G, Kornmann M, Ju J.
    Oncol Rep; 2008 Jan 01; 19(1):257-62. PubMed ID: 18097604
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J, Adleff V, Hitre E, Pap E, Réti A, Komlósi V, Budai B.
    Magy Onkol; 2007 Jan 01; 51(2):113-25. PubMed ID: 17660867
    [Abstract] [Full Text] [Related]

  • 14. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
    Okumura K, Mekata E, Shiomi H, Naitoh H, Abe H, Endo Y, Kurumi Y, Tani T.
    Cancer Chemother Pharmacol; 2008 Apr 01; 61(4):587-94. PubMed ID: 17520254
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH, Kwon HC, Oh SY, Lee DM, Lee S, Lee JH, Roh MS, Kim DC, Park KJ, Choi HJ, Kim HJ.
    Am J Clin Oncol; 2009 Feb 01; 32(1):38-43. PubMed ID: 19194123
    [Abstract] [Full Text] [Related]

  • 16. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma.
    Wong NA, Brett L, Stewart M, Leitch A, Longley DB, Dunlop MG, Johnston PG, Lessells AM, Jodrell DI.
    Br J Cancer; 2001 Dec 14; 85(12):1937-43. PubMed ID: 11747337
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients: association with survival.
    Tanaka-Nozaki M, Tajiri T, Tanaka N, Furukawa K, Takasaki H, Yoshimura K, Suzuki H, Naito Z, Sugizaki Y, Merk HF, Blömeke B, Kato S.
    Oncol Rep; 2003 Dec 14; 10(5):1425-9. PubMed ID: 12883718
    [Abstract] [Full Text] [Related]

  • 19. Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients.
    Kuramochi H, Tanaka K, Oh D, Lehman BJ, Dunst CM, Yang DY, De Meester SR, Hagen JA, Danenberg KD, De Meester TR, Danenberg PV.
    Int J Oncol; 2008 Jan 14; 32(1):201-8. PubMed ID: 18097560
    [Abstract] [Full Text] [Related]

  • 20. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R, Rosenberg R, Stricker D, Werner M, Lassmann S, Ulm K, Nekarda H, Siewert JR.
    Cancer; 2002 Nov 15; 95(10):2103-11. PubMed ID: 12412163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.